Clinical trials
Active, not recruiting Breast Neoplasms trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Pfizer | 4 |
| Hoffmann-La Roche | 2 |
| Celcuity Inc | 1 |
| Daehwa Pharmaceutical Co., Ltd. | 1 |
| MedSIR | 1 |
| Novartis Pharmaceuticals | 1 |
| Olema Pharmaceuticals, Inc. | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 18 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Breast Diseases | 2 |
| Neoplasms by Site | 2 |
| Ovarian Neoplasms | 2 |
| Recurrence | 2 |
| Skin Diseases | 1 |
| Small Cell Lung Carcinoma | 1 |
| Unilateral Breast Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.